Colchicine for the primary prevention of cardiovascular events.

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the clinical benefit and harms of colchicine as primary prevention of cardiovascular outcomes in the general population.pre-print346 K

Liver support systems for adults with acute‐on‐chronic liver failure.

This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the benefits and harms of liver support systems for adults with acute‐on‐chronic liver failure.post-print900 K

Interleukin‐receptor antagonist and tumor necrosis factor inhibitors for theprimary and secondary prevention of atherosclerotic cardiovascular diseases.

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the clinical benefits and harms of interleukin‐receptor antagonists and tumor necrosis factor (TNF) inhibitors for the primary and secondary prevention of atherosclerotic cardiovascular diseases. To determine whether interleukin‐receptor antagonists or TNF inhibitors, provided to people both with and without pre‐existing cardiovascular disease, are: useful in preventing adverse cardiovascular outcomes; and safe.post-print2743 K